These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17109356)

  • 1. Is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine?
    Gargiullo PM; Murphy TV; Davis RL
    J Infect Dis; 2006 Dec; 194(12):1793-4; author reply 1794-5. PubMed ID: 17109356
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "Age dependence of the risk of intussusception following tetravalent rhesus-human reassortant rotavirus tetravalent vaccine: is it beyond doubt?".
    Ruiz LP
    Am J Epidemiol; 2010 Oct; 172(7):864. PubMed ID: 20682522
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More on RotaShield and intussusception: the role of age at the time of vaccination.
    Simonsen L; Viboud C; Elixhauser A; Taylor RJ; Kapikian AZ
    J Infect Dis; 2005 Sep; 192 Suppl 1():S36-43. PubMed ID: 16088803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception.
    Kapikian AZ; Simonsen L; Vesikari T; Hoshino Y; Morens DM; Chanock RM; La Montagne JR; Murphy BR
    J Infect Dis; 2005 Sep; 192 Suppl 1():S22-9. PubMed ID: 16088801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Merck's oral rotavirus vaccine RotaTeq suspected to cause invagination in infants].
    Zetterström R
    Lakartidningen; 2007 Feb 28-Mar 6; 104(9):646. PubMed ID: 17393857
    [No Abstract]   [Full Text] [Related]  

  • 7. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):577-81. PubMed ID: 10428095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccines.
    Ruiz LP
    N Engl J Med; 2006 Apr; 354(16):1747-51; author reply 1747-51. PubMed ID: 16625743
    [No Abstract]   [Full Text] [Related]  

  • 10. Age dependence of the risk of intussusception following [corrected] rhesus-human reassortant rotavirus tetravalent vaccine: is it beyond doubt?
    Chen J; Heyse JF; Heaton P; Kuter BJ
    Am J Epidemiol; 2010 May; 171(9):1046-54. PubMed ID: 20400464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(34):786-9. PubMed ID: 15343145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intussusception and an oral rotavirus vaccine.
    Nakagomi T
    N Engl J Med; 2001 Jun; 344(24):1866; author reply 1866-7. PubMed ID: 11407353
    [No Abstract]   [Full Text] [Related]  

  • 13. Withdrawal of rotavirus vaccine recommendation.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Nov; 48(43):1007. PubMed ID: 10577495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intussusception and an oral rotavirus vaccine.
    DeWolfe Miller F
    N Engl J Med; 2001 Jun; 344(24):1866; author reply 1866-7. PubMed ID: 11407352
    [No Abstract]   [Full Text] [Related]  

  • 15. Rotavirus vaccines.
    Simonsen L; Taylor RJ; Kapikian AZ
    N Engl J Med; 2006 Apr; 354(16):1747-51; author reply 1747-51. PubMed ID: 16625742
    [No Abstract]   [Full Text] [Related]  

  • 16. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception.
    Rothman KJ; Young-Xu Y; Arellano F
    J Infect Dis; 2006 Mar; 193(6):898; author reply 898-9. PubMed ID: 16479526
    [No Abstract]   [Full Text] [Related]  

  • 18. RotaShield: the ill-fated rhesus-human reassortant rotavirus vaccine.
    Matson DO
    Pediatr Ann; 2006 Jan; 35(1):44-50. PubMed ID: 16466075
    [No Abstract]   [Full Text] [Related]  

  • 19. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus vaccine and intussusception. Where do we go from here?
    Dennehy PH; Bresee JS
    Infect Dis Clin North Am; 2001 Mar; 15(1):189-207, x-xi. PubMed ID: 11301815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.